Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> D >> 4,5-Dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide

4,5-Dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
[CAS# 1034616-18-6]

List of Suppliers
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Chemical manufacturer
chemBlink standard supplier since 2010
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Chemical manufacturer
chemBlink standard supplier since 2010
Amadis Chemical Co., Ltd. China Inquire  
+86 (571) 8992-5085
sales@amadischem.com
Chemical manufacturer since 2010
chemBlink standard supplier since 2015
LKT Laboratories, Inc. USA Inquire  
+1 (888) 558-5227
peacerli@mbolin-lktlabs.com
Chemical manufacturer
Complete supplier list of 4,5-Dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
Identification
Classification Biochemical >> Inhibitor >> Cell cycle >> PLK inhibitor
Name 4,5-Dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
Molecular Structure CAS # 1034616-18-6, 4,5-Dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
Molecular Formula C24H27F3N8O3
Molecular Weight 532.52
CAS Registry Number 1034616-18-6
Properties
Solubility Very slightly soluble (0.16 g/L) (25 ºC), Calc.*
Density 1.57±0.1 g/cm3 (20 ºC 760 Torr), Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2014 ACD/Labs)
Safety Data
SDS Available
Market Analysis Reports
List of Reports Available for 4,5-Dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
Related Products
3,4-Dihydro-3-(2-hydroxy-3,4-dimethoxyphenyl)-2H-1-benzopyran-7-yl beta-D-glucopyranoside  (5Z)-3,5-Dihydro-5-[(4-hydroxy-3,5-dimethoxyphenyl)methylene]-2,3-dimethyl-4H-imidazol-4-one  2,3-Dihydro-3-hydroxy-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-inden-1-one  2,3-Dihydro-4-hydroxy-2,2-dimethyl-6-benzofurancarboxylic acid  1-(3,4-Dihydro-5-hydroxy-2,2-dimethyl-2H-1-benzopyran-8-yl)-3-(4-hydroxyphenyl)-2-propen-1-one  1,3-Dihydro-1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-6-amine  1,3-dihydro-1-hydroxy-3,3-dimethyl-2,1-Benzoxaborole  1,3-Dihydro-1-hydroxy-3,3-dimethyl-2,1-benzoxaborole-6-methanamine  1,4-Dihydro-3-hydroxy-1,4-dioxo-2-naphthalenecarboxamide  5-[3-[(1R)-2,3-Dihydro-1-[(2-hydroxyethyl)amino]-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-(1-methylethoxy)benzonitrile  1,5-Dihydro-1-(2-hydroxyethyl)-6-methyl-4H-pyrazolo[3,4-d]pyrimidin-4-one  10,11-Dihydro-N-(2-hydroxyethyl)-N-methyl-5H-pyrido[2,3-c][2]benzazepine-10-carboxamide  N-[(1S)-2-[[(7S)-6,7-Dihydro-5-(2-hydroxyethyl)-6-oxo-5H-pyrido[3,2-a][3]benzazepin-7-yl]amino]-1-methyl-2-oxoethyl]-4,4,4-trifluorobutanamide  6,7-Dihydro-6-(2-hydroxyethyl)-5H-pyrrolo[3,4-b]pyridin-5-one  2,4-Dihydro-2-[4-[(2-hydroxyethyl)sulphonyl]phenyl]-5-methyl-3H-pyrazol-3-one  (2R)-2,3-Dihydro-6-(2-hydroxyethyl)-2,5,7-trimethyl-1H-inden-1-one  2,5-Dihydro-5-hydroxy-2-furanone  Dihydro-4-hydroxy-2(3H)-furanone  3,7-Dihydro-1-(5-hydroxyhexyl)-3,7-di(methyl-d3)-1H-purine-2,6-dione  3,4-Dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-2H-1-benzopyran-7-yl beta-D-glucopyranosiduronic acid